1. Home
  2. CCRN vs ACIU Comparison

CCRN vs ACIU Comparison

Compare CCRN & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • ACIU
  • Stock Information
  • Founded
  • CCRN 1986
  • ACIU 2003
  • Country
  • CCRN United States
  • ACIU Switzerland
  • Employees
  • CCRN N/A
  • ACIU N/A
  • Industry
  • CCRN Professional Services
  • ACIU Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCRN Consumer Discretionary
  • ACIU Health Care
  • Exchange
  • CCRN Nasdaq
  • ACIU Nasdaq
  • Market Cap
  • CCRN 322.9M
  • ACIU 332.4M
  • IPO Year
  • CCRN N/A
  • ACIU 2016
  • Fundamental
  • Price
  • CCRN $17.97
  • ACIU $2.68
  • Analyst Decision
  • CCRN Buy
  • ACIU Strong Buy
  • Analyst Count
  • CCRN 3
  • ACIU 2
  • Target Price
  • CCRN $18.31
  • ACIU $12.00
  • AVG Volume (30 Days)
  • CCRN 1.4M
  • ACIU 132.5K
  • Earning Date
  • CCRN 02-19-2025
  • ACIU 11-05-2024
  • Dividend Yield
  • CCRN N/A
  • ACIU N/A
  • EPS Growth
  • CCRN N/A
  • ACIU N/A
  • EPS
  • CCRN N/A
  • ACIU N/A
  • Revenue
  • CCRN $1,448,099,000.00
  • ACIU $48,505,404.00
  • Revenue This Year
  • CCRN N/A
  • ACIU $85.33
  • Revenue Next Year
  • CCRN N/A
  • ACIU $80.69
  • P/E Ratio
  • CCRN N/A
  • ACIU N/A
  • Revenue Growth
  • CCRN N/A
  • ACIU 4097200.00
  • 52 Week Low
  • CCRN $9.58
  • ACIU $2.25
  • 52 Week High
  • CCRN $23.64
  • ACIU $5.14
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 78.44
  • ACIU 27.49
  • Support Level
  • CCRN $17.81
  • ACIU $2.62
  • Resistance Level
  • CCRN $17.97
  • ACIU $3.02
  • Average True Range (ATR)
  • CCRN 0.10
  • ACIU 0.15
  • MACD
  • CCRN -0.03
  • ACIU -0.05
  • Stochastic Oscillator
  • CCRN 42.11
  • ACIU 9.52

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: